| 2021 | Nationwide pharmacovigilance data for cetuximab-induced anaphylaxis and predictive model validation using prospective specific IgE detection
| WORLD ALLERGY ORGANIZATION JOURNAL |
| 2015 | Novel methods for clinical risk stratification in patients with colorectal liver metastases
| CANCER RESEARCH AND TREATMENT |
| 2024 | Nuclear Localization of Yes-Associated Protein Is Associated With Tumor Progression in Cutaneous Melanoma
| LABORATORY INVESTIGATION |
| 2020 | Objectively measured physical activity during chemotherapy in colon cancer patients | SUPPORTIVE CARE IN CANCER |
| 2017 | Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition | ONCOGENE |
| 2020 | Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma | EUROPEAN JOURNAL OF CANCER |
| 2021 | Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma
| JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea
| PALLIATIVE MEDICINE REPORTS |
| 2022 | Oxaliplatin (3 months v 6 months) With 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients With Stage II/III Colon Cancer: KCSG CO09-07 | JOURNAL OF CLINICAL ONCOLOGY |
| 2016 | p16 Hypermethylation and KRAS Mutation Are Independent Predictors of Cetuximab Plus FOLFIRI Chemotherapy in Patients with Metastatic Colorectal Cancer
| CANCER RESEARCH AND TREATMENT |
| 2021 | Patterns of Locoregional Recurrence after Radical Cystectomy for Stage T3-4 Bladder Cancer: A Radiation Oncologist's Point of View
| YONSEI MEDICAL JOURNAL |
| 2023 | Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial
| JOURNAL OF CLINICAL ONCOLOGY |
| 2024 | Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial
| EUROPEAN UROLOGY |
| 2012 | Perfusion MRI for the prediction of treatment response after preoperative chemoradiotherapy in locally advanced rectal cancer | EUROPEAN RADIOLOGY |
| 2022 | Periodontal disease and cancer risk: A nationwide population-based cohort study
| FRONTIERS IN ONCOLOGY |
| 2013 | Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2020 | Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours
| BRITISH JOURNAL OF CANCER |
| 2008 | Phase I trial of neoadjuvant concurrent chemoradiotherapy with S-1 and weekly irinotecan in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2023 | Phase II study of a trastuzumab biosimilar in combination with paclitaxel for HER2-positive recurrent or metastatic urothelial carcinoma: KCSG GU18-18
| ESMO OPEN |
| 2008 | Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
| ANNALS OF ONCOLOGY |
| 2007 | Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib | JOURNAL OF CLINICAL ONCOLOGY |
| 2010 | Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer | RADIOTHERAPY AND ONCOLOGY |
| 2011 | Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer | INVESTIGATIONAL NEW DRUGS |
| 2015 | PINCH-2 presents functional copy number variation and suppresses migration of colon cancer cells by paracrine activity | INTERNATIONAL JOURNAL OF CANCER |
| 2009 | Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2014 | Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme linked immunosorbent assays (ELISAs) for biomarkers | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
| 2021 | Prediction of Immune-Checkpoint Blockade Monotherapy Response in Patients With Melanoma Based on Easily Accessible Clinical Indicators
| FRONTIERS IN ONCOLOGY |
| 2018 | Predictive Nomogram for Recurrence of Stage I Colorectal Cancer After Curative Resection | CLINICAL COLORECTAL CANCER |
| 2011 | Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer | ANTI-CANCER DRUGS |
| 2017 | Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2022 | Primary results of STRONG: An open-label, multicenter, phase 3b study of fixed-dose durvalumab monotherapy in previously treated patients with urinary tract carcinoma
| EUROPEAN JOURNAL OF CANCER |
| 2018 | Prognoses and Clinical Outcomes of Primary and Recurrent Uveal Melanoma.
| CANCER RESEARCH AND TREATMENT |
| 2013 | Prognostic Value of Mucinous Histology Depends on Microsatellite Instability Status in Patients with Stage III Colon Cancer Treated with Adjuvant FOLFOX Chemotherapy: A Retrospective Cohort Study | ANNALS OF SURGICAL ONCOLOGY |
| 2017 | Quality of life among Korean gastrointestinal cancer survivors
| EUROPEAN JOURNAL OF ONCOLOGY NURSING |
| 2013 | Quantitation and pharmacokinetics of 1,4-diamino-2,3-dicyano-1,4-bis (2-aminophenylthio) butadiene (U0126) in rat plasma by liquid chromatography-tandem mass spectrometry | JOURNAL OF SEPARATION SCIENCE |
| 2012 | Quantitative analysis of ERK signaling inhibition in colon cancer cell lines using phospho-specific flow cytometry | ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY |
| 2013 | Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors
| SUPPORTIVE CARE IN CANCER |
| 2023 | Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
| JOURNAL OF CLINICAL ONCOLOGY |
| 2023 | Real-World Study Evaluating Safety and Effectiveness of Axitinib in Korean Patients with Renal Cell Carcinoma after Failure of One Prior Systemic Therapy
| CANCER RESEARCH AND TREATMENT |
| 2017 | Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer
| JOURNAL OF RADIATION RESEARCH |
| 2013 | Relationship between Angiographic Late Loss and 5-Year Clinical Outcome after Drug-Eluting Stent Implantation
| YONSEI MEDICAL JOURNAL |
| 2012 | Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria | AMERICAN JOURNAL OF ROENTGENOLOGY |
| 2015 | Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine
| CANCER RESEARCH AND TREATMENT |
| 2017 | Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after preoperative chemoradiation therapy and surgery
| BMC CANCER |
| 2021 | Role of Preoperative Chemoradiotherapy in Clinical Stage II/III Rectal Cancer Patients Undergoing Total Mesorectal Excision: A Retrospective Propensity Score Analysis
| FRONTIERS IN ONCOLOGY |
| 2023 | Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort study
| ESMO OPEN |
| 2011 | Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2019 | Screening for Lung Cancer Using Low-dose Chest Computed Tomography in Korean Long-term Colorectal Cancer Survivors
| Journal of Cancer Prevention |
| 2023 | Short-Term Outcomes and Cost-Effectiveness between Long-Course Chemoradiation and Short-Course Radiotherapy for Locally Advanced Rectal Cancer
| YONSEI MEDICAL JOURNAL |
| 2011 | Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles. | ONCOLOGY |
| 2017 | Sunrise in melanoma management: Time to focus on melanoma burden in Asia | ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY |
| 2022 | Suppression of DYRK1A/B Drives Endoplasmic Reticulum Stress-mediated Autophagic Cell Death Through Metabolic Reprogramming in Colorectal Cancer Cells | ANTICANCER RESEARCH |
| 2021 | Synthesis of novel 1H-Pyrazolo[3,4-b]pyridine derivatives as DYRK 1A/1B inhibitors | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS |
| 2017 | Telomerase reverse transcriptase (TERT) promoter mutations in Korean melanoma patients
| AMERICAN JOURNAL OF CANCER RESEARCH |
| 2021 | The Awareness and Usage of Big Data for Cancer in Korea: A Survey Study
| Journal of Health Informatics and Statistics(보건정보통계학회지) |
| 2008 | The combination of capecitabine and irinotecan in treating 5-Fluorouracil- and Oxaliplatin-pretreated metastatic colorectal cancer | CANCER CHEMOTHERAPY AND PHARMACOLOGY |
| 2022 | The efficacy of immune checkpoint inhibitors in elderly patients: a meta-analysis and meta-regression
| ESMO OPEN |
| 2013 | The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY |
| 2008 | The number of residual metastatic lymph nodes following neoadjuvant chemotherapy predicts survival in patients with stage III NSCLC. | LUNG CANCER |
| 2022 | The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma
| THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |
